PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 TARGET ONCOL 杂志介绍 收藏
缩写名/全名
TARGET ONCOL
Targeted Oncology
ISSN号 1776-2596
研究方向 医学-肿瘤学
影响因子 2015:3.197, 2016:3.438, 2017:3.877, 2018:3.683, 2019:4.036,
出版国家 FRANCE
出版周期 Quarterly
年文章数 68
出版年份 2006
是否OA No
审稿周期(仅供参考) >12周,或约稿
录用比例 较易
投稿链接 https://www.editorialmanager.com/targ/default.aspx
投稿官网 http://www.springer.com/medicine/internal/journal/11523
h-index 35
CiteScore
CiteScoreSJRSNIPCiteScore排名
3.391.3220.862
学科分区排名
大类:Medicine
小类:Pharmacology (medical)
Q140 / 232
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q177 / 191
大类:Medicine
小类:Oncology
Q184 / 321

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1776-2596%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
ONCOLOGY
肿瘤学
1区1区3区
中科院SCI期刊分区
( 2020年新版本)
大类学科小类学科Top期刊综述期刊
医学 3区3区4区
ONCOLOGY
肿瘤学
2区3区3区
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.Distribution of <Emphasis Type="Italic">ALK</Emphasis> Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib

Author: Yudong Su, Xiang Long, Yang Song, Peng Chen, Shanqing Li, Huaxia Yang, Pancheng Wu, Yanyu Wang, Zhongxing Bing, Zhili Cao, Lei Cao, Yijun Wu, Zhe Zhang, Jing Liu, Bing Li, Jianxing Xiang, Ke Ma, Tengfei Zhang, Lu Zhang, Xinru Mao, Hao Liu, Puyuan Xing, Naixin Liang
Journal: Targeted Oncology, 2019, Vol., , DOI:10.1007/s11523-019-00631-x
    DOI
2.Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study

Author: Xiaonan Hong, Yuqin Song, Huiqiang Huang, Bing Bai, Huilai Zhang, Xiaoyan Ke, Yuankai Shi, Jun Zhu, Guodong Lu, Stefan Liebscher, Chunxiao Cai
Journal: Targeted Oncology, 2019, Vol., , DOI:10.1007/s11523-019-00630-y
    DOI
3.Clinical Management of Non-Small Cell Lung Cancer with Concomitant <Emphasis Type="Italic">EGFR</Emphasis> Mutations and <Emphasis Type="Italic">ALK</Emphasis> Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib

Author: Yiming Zhao, Shuyuan Wang, Bo Zhang, Rong Qiao, Jianlin Xu, Lele Zhang, Yanwei Zhang, Baohui Han
Journal: Targeted Oncology, 2019, Vol., , DOI:10.1007/s11523-019-00628-6
    DOI
4.Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors

Author: Xiang Chen, JiaXi Yao, Li Liu, WenZhong Zheng, XiaoYi Hu, YanJun Zhu, Hang Wang, JianMing Guo
Journal: Targeted Oncology, 2019, Vol., , DOI:10.1007/s11523-019-00625-9
    DOI
5.Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy

Author: Zhuanglin Li, Mingxue Wang, Xuejing Yao, Wenting Luo, Yaocheng Qu, Deling Yu, Xue Li, Jianmin Fang, Changjiang Huang
Journal: Targeted Oncology, 2019, Vol., , DOI:10.1007/s11523-018-0616-8
    DOI
6.Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy

Author: Xia Yang, Jia Rao, Wentao Yang, Ruohong Shui
Journal: Targeted Oncology, 2018, Vol.13, 757-767, DOI:10.1007/s11523-018-0602-1
    DOI
7.Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis

Author: Gaofeng Pan, Shaobo Ke, Jinping Zhao
Journal: Targeted Oncology, 2013, Vol.8, 107-116, DOI:10.1007/s11523-013-0272-y
    DOI
8.Hyperbaric oxygen and cancer: more complex than we expected

Author: Liu Wenwu, Sun Xuejun, Tao Hengyi, Liu Kan
Journal: Targeted Oncology, 2013, Vol.8, 79-81, DOI:10.1007/s11523-013-0259-8
    DOI
9.Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis

Author: Xue Li, Minghuan Li, Zhen Lian, Hui Zhu, Li Kong, Ping Wang, Jinming Yu
Journal: Targeted Oncology, 2016, Vol.11, 753-761, DOI:10.1007/s11523-016-0451-8
    DOI
10.RETRACTED ARTICLE: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8

Author: Ying Wang, Po Xu, Jun Yao, Ruina Yang, Zhenguo Shi, Xiaojuan Zhu, Xiaoshan Feng, Shegan Gao
Journal: Targeted Oncology, 2015, Vol.11, 197-207, DOI:10.1007/s11523-015-0390-9
    DOI
同类著名期刊名称 h-index CiteScore
CA-A CANCER JOURNAL FOR CLINICIANS144160.19
Nature Reviews Clinical Oncology1278.04
NATURE REVIEWS CANCER39623.23
LANCET ONCOLOGY27410.07
JOURNAL OF CLINICAL ONCOLOGY49411.08
CANCER CELL29515.04
ANNALS OF ONCOLOGY2108.44
SEMINARS IN CANCER BIOLOGY1348.86
CLINICAL CANCER RESEARCH2928.32
CANCER RESEARCH4116.94
中科院JCR同大类学科的热搜期刊 浏览次数
MEDICINE294305
CANCER RESEARCH165008
Molecular Medicine Reports163610
International Journal of Nanomedicine163516
CANCER LETTERS158538
JOURNAL OF ETHNOPHARMACOLOGY140619
BIOMEDICINE & PHARMACOTHERAPY139189
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY135118
Theranostics134718
International Journal of Environmental Research and Public Health132756